CLBT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

14.809

Open

13.360

VWAP

14.30

Vol

4.60M

Mkt Cap

3.67B

Low

13.360

Amount

65.78M

EV/EBITDA(TTM)

--

Total Shares

249.44M

EV

--

EV/OCF(TTM)

--

P/S(TTM)

--

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

Show More

Events Timeline

(ET)

2026-05-14

07:20:00

Sees 2026 Adjusted EBITDA of $149M-$155M

2026-05-14

07:10:00

Cellebrite Q1 Revenue $128.3M Exceeds Expectations

2026-05-14

07:10:00

Sees Q2 Adjusted EBITDA of $29M-$31M

2026-05-06 (ET)

2026-05-06

08:50:00

Cellebrite Government Cloud Achieves FedRAMP High Authorization

2026-03-16 (ET)

2026-03-16

08:50:00

Cellebrite Launches Revolutionary AI Product Genesis

News

CNBC

Wall Street's Latest Rating Changes Overview

seekingalpha

05-14seekingalpha

Cellebrite Exceeds Q1 2026 Earnings Expectations

Fool

Cisco's Transformation in the AI Era

PRnewswire

05-14PRnewswire

Cellebrite Reports 21% ARR Growth in Q1 2026

seekingalpha

05-14seekingalpha

Cellebrite Q1 Earnings Exceed Expectations

seekingalpha

05-13seekingalpha

Cellebrite to Announce Q1 Earnings on May 14

7 Analyst Rating

Wall Street analysts forecast CLBT stock price to rise

7 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

23.00

Averages

24.83

High

28.00

Current: 0.000

Low

23.00

Averages

24.83

High

28.00

DA Davidson

Buy

initiated

$20

AI Analysis

2026-05-26

New

Reason

DA Davidson

Price Target

$20

AI Analysis

2026-05-26

New

initiated

Buy

Reason

DA Davidson initiated coverage of Cellebrite with a Buy rating and $20 price target. The company's total addressable market is large, growing, and likely understated, the analyst tells investors in a research note. The stock also offers multiple drivers of continued wallet share gains and achievement of guided to organic annualized recurring revenue growth acceleration, the firm added.

Needham

Buy

downgrade

$18 -> $15

2026-05-15

Reason

Needham

Price Target

$18 -> $15

2026-05-15

downgrade

Buy

Reason

Needham lowered the firm's price target on Cellebrite to $15 from $18 and keeps a Buy rating on the shares. The company's Q1 results outperformed consensus estimates across the board, though the firm is reducing its price target to reflect multiple compression, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CLBT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Cellebrite DI Ltd (CLBT.O) is 35.71, compared to its 5-year average forward P/E of 46.09. For a more detailed relative valuation and DCF analysis to assess Cellebrite DI Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

46.09

Current PE

35.71

Overvalued PE

69.36

Undervalued PE

22.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

28.50

Current EV/EBITDA

49.96

Overvalued EV/EBITDA

40.28

Undervalued EV/EBITDA

16.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

5.62

Current PS

4.93

Overvalued PS

7.97

Undervalued PS

3.27

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

best swing trades $10-$20

Intellectia · 209 candidates

Price: $10.00 - $20.00Rsi Category: moderateMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $-5.00 - $15.00Macd: bullish

Ticker

Name

Market Cap$

Cellebrite DI Ltd

3.79B

Aeva Technologies Inc

901.80M

Sound Point Meridian Capital Inc

217.22M

Navan Inc

2.58B

Green Plains Inc

1.06B

Unusual Machines Inc

559.45M

let me seethedaytrading stocks

Intellectia · 41 candidates

Price: $5.00 - $50.00Relative Vol: >= 2Beta: HighRiskWeekly Average Turnover: >= 2,000,000

Ticker

Name

Market Cap$

NeoVolta Inc

191.06M

Centessa Pharmaceuticals PLC

3.39B

Zura Bio Ltd

410.95M

Intrepid Potash Inc

456.52M

Dime Community Bancshares Inc

1.44B

Cellebrite DI Ltd

3.85B

find stock with increasing volume

Intellectia · 114 candidates

Market Cap: 500.00M - 5.00BRelative Vol: >= 2

Ticker

Name

Market Cap$

Plexus Corp

4.86B

Mirum Pharmaceuticals Inc

4.82B

Icahn Enterprises LP

4.81B

ServisFirst Bancshares Inc

4.78B

Rush Enterprises Inc

4.68B

Texas Capital Bancshares Inc

4.67B

what stock is bearish today

Intellectia · 65 candidates

Relative Vol: >= 2Moving Average Relationship: PriceBelowMA20Candlestick Pattern: BlackCandlestickWeek Price Change Pct: <= $-3.00Support Resistance Relationship: PriceFallBelowSupport

Ticker

Name

Market Cap$

Abbott Laboratories

209.93B

Shopify Inc

180.36B

Cloudflare Inc

59.54B

Sempra

56.12B

Broadridge Financial Solutions Inc

24.15B

Equitable Holdings Inc

13.11B

Whales Holding CLBT

Portolan Capital Management, LLC

More Investment House Ltd.

Meitav Investment House Ltd

Clal Financial Management Ltd

Migdal Mutual Funds Ltd.

Phoenix Investments & Finances Ltd

Trading Trends

People Also Watch

Frequently Asked Questions

What is Cellebrite DI Ltd (CLBT) stock price today?

The current price of CLBT is 14.73 USD — it has increased 11.59

What is Cellebrite DI Ltd (CLBT)'s business?

Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.

What is the price predicton of CLBT Stock?

Wall Street analysts forecast CLBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLBT is24.83 USD with a low forecast of 23.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cellebrite DI Ltd (CLBT)'s revenue for the last quarter?

Cellebrite DI Ltd revenue for the last quarter amounts to 128.30M USD, increased 19.30

What is Cellebrite DI Ltd (CLBT)'s earnings per share (EPS) for the last quarter?

Cellebrite DI Ltd. EPS for the last quarter amounts to 0.04 USD, decreased -42.86

How many employees does Cellebrite DI Ltd (CLBT). have?

Cellebrite DI Ltd (CLBT) has 1285 emplpoyees as of May 31 2026.

What is Cellebrite DI Ltd (CLBT) market cap?

Today CLBT has the market capitalization of 3.67B USD.